Everolimus‐Eluting versus Paclitaxel‐Eluting Stents in Percutaneous Coronary Intervention: Meta‐Analysis of Randomized Trials

Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, and conference proceedings were searched for randomized trials comparing everolimus versus paclitaxel-eluting stents for percutaneous coronary …